We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Low Cost POC Analyzers to Be Introduced at Medica 2012

By LabMedica International staff writers
Posted on 07 Nov 2012
The Quo-Lab glycated hemoglobin (HbA1c) analyzer for the management of diabetes, and a new strip-based analyzer, the STAT-Site M bHB for near patient testing of ketosis, will be introduced at Medica 2012, in Dusseldorf (Germany) during November 14-16, 2012. More...
The analyzers are a product of EKF Diagnostics (Cardiff, United Kingdom).

The semi-automated Quo-Lab HbA1c analyzer is CE marked and provides accurate, affordable, and easy-to-use technology for GP surgeries, diabetes clinics, and laboratories. HbA1c monitoring is increasingly used in the detection and management of diabetes and Quo-Lab is designed to meet the needs of resource poor countries where diabetes is increasing. Only 4 µL of venous or finger prick blood is required for the test and results are available within four minutes.

EKF's first strip-based ketone analyzer, the Stat-Site M bHB promises to take testing for ketoacidosis out of the laboratory and into the emergency room. Beta-Hydroxybutyrate (bHB) is the main ketone produced during ketosis and provides a quantitative and accurate assessment of patients displaying symptoms of ketosis.

The launch of STAT Site M bHB follows the recent release of the b-Hydroxybutyrate (bHB) LiquiColor Reagent System developed by the EKF subsidiary, Stanbio Laboratory.

Related Links:

EKF Diagnostics



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Pipette
Accumax Smart Series
New
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.